Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].

Der Nervenarzt - 1 Feb 2003

Krasnianski M, Neudecker S, Eger K, Schulte-Mattler W, Zierz S

Abstract excerpt

Although the gene for facioscapulohumeral muscular dystrophy (FSHD) has not been identified so far, 4q35 deletion represents a diagnostic marker of the disease. In the present study, 46 consecutive symptomatic patients with 4q35 FSHD deletions or typical FSHD clinical features were evaluated. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Child, Preschool
Share to Chromosome Deletion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 4

Share to Electromyography

Share to Muscle, Skeletal

Share to Muscular Dystrophy, Facioscapulohumeral

Share to Neurologic Examination

Source

Identifiers

PMID: 12596016
DOI: 10.1007/s00115-002-1455-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-12596016-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].PMID 12596016Read ↗

[Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].Semantic proximity Read ↗

[Clinical and genetic characteristics of facioscapulohumeral muscular dystrophy Landuzi-Dezherina type 1].Semantic proximity Read ↗

[Clinical and molecular diagnosis of facioscapulohumeral dystrophy type 1 (FSHD1) in 2012].Semantic proximity Read ↗

Facioscapulohumeral Muscular Dystrophy: More Complex than it AppearsSemantic proximity Read ↗

Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium.Semantic proximity Read ↗

Facioscapulohumeral muscular dystrophy.Semantic proximity Read ↗

[Role of associated alleles and hypomethylation status in the clinical expression of facioscapulohumeral muscular dystrophy].Semantic proximity Read ↗

Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletionSemantic proximity Read ↗

Facioscapulohumeral DystrophySemantic proximity Read ↗

Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.Semantic proximity Read ↗

[Clinical phenotype and genotype of early-onset facioscapulohumeral muscular dystrophy type 1].Semantic proximity Read ↗

Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.